SINGAPORE--SingTel has announced that it is the first service provider in the Asia-Pacific region to globally deploy Multiprotocol Label Switching-Transport Profile (MPLS-TP) technology for its ConnectPlus E-Line service, providing its multinational corporation (MNC) customers with scalable high-speed connections worldwide. Using the Cisco® MPLS Transport Profile (MPLS-TP) suite of Carrier Packet Transport technologies -- SingTel's customers can now enjoy data bandwidths of up to 10 gigabits per second to support bandwidth-intensive applications with high service reliability across their global offices. In the coming year, SingTel will use this platform to deliver dedicated point-to-multipoint and electronic Bandwidth-On-Demand (eBOD) for ConnectPlus E-Line services.
Thursday, November 29, 2012
LONDON, U.K.--GSK welcomes the publication of the third Access to Medicines (ATM) Index, which measures the performance of the top 20 pharmaceutical companies on their efforts to improve access to medicines and healthcare in developing countries. GSK has been ranked top of the Index in 2012 for the third time of publishing, scoring highest in four categories including general access to medicine management, research and development activity, capability advancement and drug donation and philanthropy.
RESEARCH TRIANGLE PARK, N.C.--RTI International’s nanofiber lighting improvement technology (NLITe™) won the Energy Institute’s 2012 Innovation Award. The Energy Institute awards recognize individuals and organizations in the global energy industry for setting new standards of excellence and innovation. NLITe™ is an innovative technology platform for the lighting industry that enables substantial energy savings and produces aesthetically pleasing light. The technology has been validated in the marketplace and at third party testing labs where it has been shown to improve light output by as much as 40 percent in common lighting fixtures. The Energy Institute is the professional body for the energy industry and supports roughly 15,000 individuals and 250 companies across 100 countries.
BERLIN--Bayer HealthCare and Leiden University of The Netherlands will coordinate a newly founded international consortium, dubbed “K4DD” (Kinetics for Drug Discovery), which has been launched to explore a novel concept in modern drug discovery and to tackle a big problem in the development of new drugs. Although successful in early phases of development, many drug candidates fail in clinical studies due to lack of efficacy. The new five-year project will focus on ‘optimizing binding kinetics’ for drug candidates with the goal of improving drug design. The consortium is financially supported with 20 million Euro by Europe’s Innovative Medicines Initiative (IMI).
Wednesday, November 28, 2012
ARMONK, N.Y.--Holiday shoppers turned Cyber Monday into the biggest spending day ever with online sales growing 30.3 percent over the same period last year, according to cloud-based analytics findings by IBM (NYSE: IBM). With an increase in online sales across multiple channels, the digital consumer took center stage. Retailers, marketing departments and chief marketing officers (CMO) delivered a consistent customer experience across multiple channels from mobile devices, to online and to the show floor leading to the record shopping day.
MILLS RIVER, N.C.--Ginseng authorities and growers from across the nation will converge on the Mountain Horticultural Crops Research and Extension Center in Mills River, NC for the International American Ginseng Exposition on December 7th and 8th, 2012, hosted by the North Carolina Natural Products Association.
RALEIGH, N.C.--BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announces that it has received definitive commitments from institutional investors (including existing investors of the company) for an at market registered direct financing yielding gross proceeds of $40 million to BDSI. The financing is expected to close on December 3, 2012, subject to customary closing conditions.
Tuesday, November 27, 2012
MULHOUSE, FRANCE & CAMBRIDGE, MASS.--Rhenovia Pharma, a leading biotech company specialized in biosimulation applied to the discovery of new medications to treat neurodegenerative, neurological and psychiatric diseases, announces today that it has filed two patent applications for RHEpatch(TM), Rhenovia’s electronic transdermal patch for people suffering from chronic diseases.
DALLAS, TX-- iHangy® www.ihangy.com, the maker of popular Apple®-compatible protective cases and accessories, announced today the iHangy Slip in 5 Case line of protective and fashionable cases, keychains, and secure necklaces, designed specifically to protect and carry the iPhone® 5 for quick hands-free accessibility. Available in pink, white and black, the Slip in 5 Case line protects the whole body of the more delicate iPhone 5 (which is thinner and easier to drop than previous versions of the iPhone), protecting your iPhone 5 investment from scratches, cracks and impacts. The Slip in 5 Case line provides rubber-coated hard plastic in the exterior and soft cushioning silicone in the interior, keeping the iPhone handy for texting, phone calls, apps, games, music and Internet use.
RALEIGH, N.C.--Innovative creative services agency The Marketing Machine has launched a blog with detailed insights into best practices in branding, graphic design, marketing and web design. "The Werd" is available free of charge on the firm's website www.theMmachine.com/blog/. "Our new blog reflects the personality behind our company," Paul Spinak, company president said, adding, "We're experienced, talented marketing professionals who really enjoy being creative and working with one another, coming up with innovative solutions for our clients. We just don’t do it wearing suits and ties huddled around a conference table."
Tuesday, November 20, 2012
TEL AVIV, ISRAEL--Compugen Ltd. (Nasdaq: CGEN) announced today the signing of an agreement with a private U.S.-based investment company pursuant to which up to $15,000,000 in milestone related equity financing will be made available to Keddem Bioscience Ltd., currently a wholly owned subsidiary of Compugen. This financing will be used to further develop and commercialize a unique technology platform that has been designed to consistently enable the discovery of small molecule modulators (e.g., drugs, pesticides) for potentially any given protein target. Under the agreement, the new investor will obtain a majority equity interest in Keddem, with Compugen maintaining a minority interest and certain future preferential access rights to utilize the Keddem technology with Compugen discovered drug targets.
NESS ZIONA, ISRAEL--Atox Bio today reported positive top-line results from the AB103 randomized, double-blind, placebo-controlled Phase 2a trial in patients with Necrotizing Soft Tissue Infections (NSTI), a life-threatening bacterial infection with significant morbidity and high mortality rate.
Monday, November 19, 2012
ASHEVILLE, N.C.--Technology integrator TSAChoice, Inc., with offices in Asheville, NC and Greenville, SC, announces that technology consultant John Adair completed training and exams to earn a sales certification through TSAChoice’s business partner, Mitel. With Adair’s certification, all of TSAChoice’s VoIP Sales Team, Voice Engineers, and Customer Service Department have now earned the 2013 Mitel Sales Professional (MSP) certification, providing them with the knowledge and know-how to recommend, position, and design solutions to meet business technology challenges.
SANTA CLARA, CALIF.--Agilent Technologies Inc. (NYSE: A) will present at the Wireless Connectivity in Medical Devices Conference, Nov. 28. at the Langham Boston Hotel in Boston, Mass. In a keynote presentation, Jung-Ik Suh, Agilent wireless marketing program manager, will discuss the key wireless technologies that can be applied to medical devices, examine integral specifications and attributes on usage, and evaluate the testing challenges for these applications.
Wednesday, November 14, 2012
CHARLOTTE, NC--BASF today announced its plans to build a new production plant for emulsion polymers at its integrated "Verbund" site in Freeport, Texas. The new plant will allow BASF to better serve the coatings, construction, adhesives, and paper industries by expanding the network of manufacturing locations and improve the backward integration of raw materials used in production. The new plant, which is expected to begin production in mid-2014, will create approximately 25 new jobs at the Freeport site.
DURHAM, NC--MetaMetrics®, developer of The Lexile® Framework for Reading, has partnered with Amicus® Publishing to provide Lexile® measures for over 100 of their popular titles from more than 20 different series. Since 2010, Amicus has published children's books that are aimed at educating, inspiring, and encouraging children to explore and continue to grow. Amicus publishes library-bound books for preschool through middle school, cultivating the next generation of readers and thinkers. Amicus Publishing features three imprints: Amicus Readers, Amicus Illustrated, and Amicus High Interest.
RALEIGH, N.C.--Myers Bigel Sibley & Sajovec, P.A. (Myers Bigel), the largest independent patent law firm in the Carolinas, has achieved a prestigious Tier 1 designation in the 2013 "Best Law Firms" rankings from U.S. News and Best Lawyers which were recently announced on November 1st. Additionally, D. Randal Ayers has been named Lawyer of the Year, while seven of his peers garnered "Best Lawyers" awards. "The talent and dedication of the registered patent attorneys in each of our practice groups, including biotechnology, chemistry, electronics and computing, litigation, mechanical, trademark, and university, is ultimately what leads to national recognition within the legal industry," Managing Partner Jim Cannon said.
Tekelec's Diameter Signaling Router Wins Light Reading's 2012 Leading Lights Award for Best Mobile Product
MORRISVILLE, N.C.--Mobile broadband solutions company Tekelec received Light Reading's 2012 Leading Lights "Best Product (Mobile)" award for its market-leading Diameter Signaling Router (DSR). Light Reading editors recognized Tekelec as "the company that has developed a potentially market-leading product that, through engineering and technical excellence, enables the deployment of next-generation mobile services."
Monday, November 12, 2012
CARY, N.C.--Cornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on commercializing products for the hospital and related specialty markets, today announced it has entered into an agreement with Chiesi Farmaceutici S.p.A. (Chiesi) to acquire the U.S. rights to market BETHKIS® (Tobramycin Inhalation Solution) indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with FEV1 less than 40% or greater than 80% predicted, or patients colonized with Burkholderia cepacia. BETHKIS® received approval from the U.S. Food and Drug Administration (FDA) on October 12, 2012 and the licensing agreement with Chiesi, headquartered in Parma, Italy, was executed on November 6, 2012.
DURHAM, N.C.--Bell and Howell, a leading provider of solutions and services for paper-based and digital messaging, today announced it will integrate the HP C500 Color Print Module inkjet technology into its inserting and finishing systems as an option for its customers. Under the terms of the new OEM agreement with HP, Bell and Howell will market these fully-integrated systems throughout North America.
BARCELONA, SPAIN--The Spanish biotech company AB-BIOTICS has signed a 10-year license agreement which gives HanAll BioPharma exclusive rights to distribute its cholesterol-lowering probiotic AB-LIFE in South-Korea. According to clinical trial supported by the Ethics Committee of Hospital Puerta del Hierro (Madrid), AB-LIFE reduces total cholesterol levels between 14% and 18%. AB-LIFE will be released in the next six months in the Korean market, with great sales potential as the prevalence of hypercholesterolemia in that country is estimated to be 8.9% and 10.4% in men and women, respectively, according to a study by the Korea Medical Insurance Corporation.
Sunday, November 4, 2012
APEX & MANTEO, N.C.--North Carolina's OBX Outfitters (www.obxoutfitters.com) is partnering with the Outer Banks Chamber of Commerce and the Outer Banks Visitors Bureau to promote shopping local during this year's holiday season. In supporting the "shop local" push by these two organizations, the casual apparel and activewear company is offering free shipping from now until December 31st on all merchandise purchased from its Amazon.com storefront , including its new lineup of Wearable Art featuring designs by local artists. "A big part of our mission as a company is to produce wearable art for consumers with positive messages serving as a reminder of vacations, events and overall goodness in their lives," Stacy Menzies, company president, said. "The Outer Banks is a special place, and a big, big part of that is the people who live there, including a vibrant art community," she added.
Friday, November 2, 2012
PARIS, FRANCE--Ariana Pharma, the premium provider of advanced, non-statistical clinical data and biomarker analytics technology across life science industries as well as the FDA, today announces the signing of an exclusive Japanese distribution agreement with CTC Laboratory Systems Corporation (CTCLS), the Japanese supplier of services for R&D solutions.
TEL AVIV, ISRAEL--Compugen Ltd. (NASDAQ: CGEN), announced today the discovery and initial validation of two new drug target candidates for monoclonal antibody (mAb) cancer therapy. These new candidates have been shown to be expressed in multiple types of tumors and were shown to have an immunomodulatory activity in affecting both innate and adaptive immune responses, thus providing the potential for an efficient and targeted approach in cancer treatment. By offering a different mode of action from Compugen's other immune checkpoint candidates, these molecules further broaden the scope of the Company's Pipeline Program for monoclonal antibody treatment of cancer.
SAN DIEGO, CALIF.--This program is intended to provide fellowship awards to accelerate the commercialization of novel clean energy technologies developed within research institutes and universities throughout the Southern California region.
Agilent Technologies Announces Precision Low-Noise Power Source for Electronics Industry and Research
SANTA CLARA, CALIF.--Agilent Technologies Inc. (NYSE: A) today introduced two new low-noise power sources. Members of the Agilent B2900A precision instrument family, the one-channel B2961A and the two-channel B2962A are revolutionary power supplies for precision low-noise voltage/current sourcing.